Lapatinib bevarede betydelig aktivitet over for brystcancercellelinjer selekteret for langtidsvækst i trastuzumab- holdigt medium in vitro.
Lapatinib retained significant activity against breast cancer cell lines selected for long-term growth in trastuzumab-containing medium in vitro.